1.
Zhang J. FDX1 is a Potential Prognostic Biomarker Related to Cuproptosis and Immune Infiltration for Patients with Kidney Clear Cell Carcinoma. Annals KEMU [Internet]. 2024 Dec. 31 [cited 2026 Mar. 7];30(4):334-43. Available from: https://www.annalskemu.org/journal/index.php/annals/article/view/5531